 AIkido Pharma Inc. Nasdaq: AIKI AIkido or the Company, a technology development company committed to the fostering of innovative ideas, announced today the closing of its previously announced registered direct offering with several institutional and accredited investors of 14,000,000 shares of its common stock at a purchase price of 1.00 per share, priced at-the-market under Nasdaq rules. The gross proceeds to the Company from the offering totaled 14.0 million, before deducting placement agent fees and other offering expenses. 